Correction

Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study (JUL,10.1007/s00198-023-06863-y, 2023)

Journal

OSTEOPOROSIS INTERNATIONAL
Volume -, Issue -, Pages -

Publisher

SPRINGER LONDON LTD
DOI: 10.1007/s00198-023-06887-4

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available